Patent · US Active

Tuberculosis compositions and methods of using the same

US10266574B2 · kind B2 · utility

0Cited by

4References

6Claims

0Family size

Assignee

International AIDS Vaccine Initiative, Inc. · US

Inventors

Ravi P. Anantha · Gaithersburg, US
Nathalie Cadieux · New York, US
Thomas G. Evans · New York, US
Michele Stone · New York, US
Barry Walker · New York, US

Key dates

Filing date	Jun 24, 2014
Grant date	Apr 23, 2019
Priority date	—
Expiry date	Jun 24, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.